Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Prolactin and melatonin can stimulate hair growth in Cashmere goat hair follicles, but melatonin may reduce follicle viability over time.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Herbal treatments can help manage PCOS symptoms.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Physical symptoms in depression can reveal underlying medical conditions.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

SHBG binding properties are unchanged in male liver cirrhosis patients.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.